Borealis Ventures

Borealis Ventures is a venture capital firm established in 2002 and headquartered in Hanover, New Hampshire, with an additional office in Portsmouth. The firm specializes in seed to early-stage investments, focusing on emerging companies in life sciences, healthcare, digital health, information technology, and design and engineering software. Borealis Ventures is particularly dedicated to fostering innovations in 3D design, construction management, and data-driven software. The firm typically invests between $0.1 million and $2.5 million in its portfolio companies, targeting those with sales values up to $10 million and enterprise values up to $20 million. Borealis Ventures actively seeks to take board seats in its investments and prefers to lead funding rounds while also co-investing with other venture capital firms or entrepreneurs. Its investment strategy includes a national scope with a concentration on northern New England, especially around the Dartmouth College network.

Jesse Devitte

Co-Founder

Phil Ferneau

Co-Founder and Managing Director

Matt Rightmire

Managing Director

51 past transactions

Ankyra

Series B in 2021
Ankyra is a biotechnology company focused on developing anchored immunotherapy for cancer treatment. The company addresses the limitations of traditional cytokine therapies, which are often restricted due to widespread immune activation and associated toxicity. Ankyra's innovative approach involves the use of its Anchored Immunotherapy Platform to create ANK-101, a stable complex of a modified IL-12 cytokine and aluminum hydroxide, an FDA-approved adjuvant. This combination allows for targeted intratumoral delivery, enhancing the localized retention and activity of IL-12 while reducing systemic side effects. By optimizing the therapeutic potential of anchored immunotherapy, Ankyra aims to improve treatment outcomes for cancer patients, offering a safer and more effective alternative to conventional therapies.

Orbit Discovery

Venture Round in 2021
Orbit Discovery Ltd. is a biotechnology company specializing in peptide display technology to discover peptide drugs for chronic diseases. Established in 2015 and based in Oxford, United Kingdom, the company utilizes an innovative in vitro bead display platform that links randomized peptide sequences to their encoding DNA. This technology enables high-throughput screening of peptides, facilitating the identification and optimization of potential drug candidates. By combining the specificity and efficacy of large biologic molecules with the advantages of small molecules, such as lower manufacturing costs and simpler delivery methods, Orbit Discovery aims to address a wide range of chronic diseases affecting large patient populations. The company's focus is on both internal drug discovery programs and collaborative research efforts, streamlining the discovery process and accelerating the development of new peptide therapeutics.

Ovation

Series B in 2020
Ovation offers data and operations solutions tailored for the life sciences industry, focusing on enhancing the capabilities of researchers, scientists, and laboratories. The company has developed a cloud-based laboratory information management system that streamlines clinical diagnostics for molecular diagnostic labs. This system encompasses various functionalities, including lab workflows, sample tracking, document management, personnel training, and external portals. Furthermore, Ovation provides a partner ecosystem that supports revenue cycle management, clinical interpretation, consulting services, and business analytics. By enabling medical researchers and scientists to efficiently collect, organize, and visualize lab-related data, Ovation enhances their ability to make informed decisions throughout the research process.

FidoCure

Series A in 2020
FidoCure is dedicated to advancing canine cancer care through the use of AI-driven precision medicine. The company has established the largest proprietary learning database for canine cancer by utilizing data from naturally occurring cases and next-generation sequencing. FidoCure focuses on providing personalized medicine services, which go beyond traditional chemotherapy and radiation. By collecting tissue samples for DNA sequencing, the company generates detailed reports that identify genetic mutations influencing treatment options. This approach enables veterinarians and pet owners to implement targeted therapies that specifically address cancer cells, ultimately improving the quality of life for dogs facing cancer. Furthermore, FidoCure bridges the gap between human and veterinary oncology, fostering comparative oncology and creating innovative drug development opportunities that benefit both pets and humans.

Ovation

Series A in 2019
Ovation offers data and operations solutions tailored for the life sciences industry, focusing on enhancing the capabilities of researchers, scientists, and laboratories. The company has developed a cloud-based laboratory information management system that streamlines clinical diagnostics for molecular diagnostic labs. This system encompasses various functionalities, including lab workflows, sample tracking, document management, personnel training, and external portals. Furthermore, Ovation provides a partner ecosystem that supports revenue cycle management, clinical interpretation, consulting services, and business analytics. By enabling medical researchers and scientists to efficiently collect, organize, and visualize lab-related data, Ovation enhances their ability to make informed decisions throughout the research process.

Teckro

Series C in 2019
Teckro, Inc. is a life science technology company based in Limerick, Ireland, with additional offices in Dublin and Nashville. Founded in 2015, Teckro focuses on transforming clinical trials by providing a software platform that connects all stakeholders involved in clinical research, including pharmaceutical companies, clinical researchers, and study teams. The platform enables instant access to relevant information for every active member of a study, facilitating seamless communication and collaboration. By utilizing information retrieval and machine learning technologies, Teckro streamlines the clinical development process, enhancing the speed and accuracy of trials. The company's solutions ultimately aim to expedite the development of drugs and treatments for complex diseases, thereby improving outcomes in clinical research.

Evox Therapeutics

Series B in 2018
Evox Therapeutics is a biotechnology company based in Oxford, United Kingdom, founded in 2016. The company specializes in developing exosome-based therapeutics aimed at treating rare and severe diseases. By harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, Evox focuses on creating innovative drug delivery systems that utilize nucleic acids and proteins. This technology allows for targeted delivery to specific organs, including the brain and central nervous system, addressing limitations often encountered with traditional therapies. Evox's proprietary methods for modifying exosomes enhance their ability to transport therapeutic agents effectively, thereby improving treatment options for patients with limited alternatives. The company is supported by a strong intellectual property portfolio and investments from leading life sciences venture capital groups, positioning it as a leader in the emerging field of exosome-based therapeutics.

Compass Therapeutics

Series A in 2018
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.

Orbit Discovery

Series A in 2018
Orbit Discovery Ltd. is a biotechnology company specializing in peptide display technology to discover peptide drugs for chronic diseases. Established in 2015 and based in Oxford, United Kingdom, the company utilizes an innovative in vitro bead display platform that links randomized peptide sequences to their encoding DNA. This technology enables high-throughput screening of peptides, facilitating the identification and optimization of potential drug candidates. By combining the specificity and efficacy of large biologic molecules with the advantages of small molecules, such as lower manufacturing costs and simpler delivery methods, Orbit Discovery aims to address a wide range of chronic diseases affecting large patient populations. The company's focus is on both internal drug discovery programs and collaborative research efforts, streamlining the discovery process and accelerating the development of new peptide therapeutics.

Measurabl

Series A in 2018
Measurabl, Inc. is a San Diego-based company that specializes in developing a cloud-based software platform for environmental, social, and governance (ESG) data management, primarily focused on the commercial real estate sector. Founded in 2013, Measurabl's platform enables clients to efficiently collect and analyze non-financial data related to utility usage, waste management, and travel. The software facilitates the creation of investment-grade sustainability reports and provides alerts for improvement opportunities, allowing organizations to benchmark their performance and enhance their ESG initiatives. By empowering customers to assess physical climate risk and drive decarbonization, Measurabl supports the pursuit of sustainable finance opportunities and overall optimization of ESG performance.

Dandelion Energy

Seed Round in 2018
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Dandelion Energy

Seed Round in 2017
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Avitide

Series E in 2017
Avitide, Inc. is a company that specializes in the discovery, manufacturing, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, Avitide focuses on enhancing the purification of therapeutic proteins through its innovative affinity separation technology. This technology helps clients streamline bioprocess development timelines, mitigate program risks, and lower manufacturing costs while ensuring scalability for commercial applications. The company develops customized solutions for a variety of life-saving therapeutics, including enzymes, multi-specific antibodies, gene therapies, and vaccines. By utilizing rapid development techniques for chromatography resins, Avitide aims to improve drug safety and establish bio-similarity in its offerings.

Newmetrix

Series A in 2017
Newmetrix is a technology company that offers a cloud-based video management platform aimed at minimizing risks on construction job sites through the integration of human and artificial intelligence. The platform leverages machine learning to analyze images and videos from various projects, categorizing them with construction-specific tags. This capability helps clients address challenges related to management, collaboration, search, and analysis of industrial visual content, thereby enhancing safety and operational efficiency in the construction industry.

HELIX

Series B in 2015
HELIX, originally known as Flux and the first spin-out from Google X, is based in Oakland, California. The company initially focused on generative building design but shifted in 2019 to address the challenges of digitizing buildings. HELIX developed the HELIX Creator platform, which allows architects, engineers, builders, and owner-operators to utilize LiDAR and photogrammetry for capturing precise building geometry, transforming it into practical plans and models. This platform provides users with timely access to accurate 2D and 3D information, as well as essential documents and data related to buildings. HELIX's technology is instrumental in assessing building potential, planning renovations, and detailed documentation for disaster preparedness. The company emphasizes the importance of accurate and easily accessible data to fully realize the capabilities of Digital Twins.

Avitide

Series C in 2015
Avitide, Inc. is a company that specializes in the discovery, manufacturing, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, Avitide focuses on enhancing the purification of therapeutic proteins through its innovative affinity separation technology. This technology helps clients streamline bioprocess development timelines, mitigate program risks, and lower manufacturing costs while ensuring scalability for commercial applications. The company develops customized solutions for a variety of life-saving therapeutics, including enzymes, multi-specific antibodies, gene therapies, and vaccines. By utilizing rapid development techniques for chromatography resins, Avitide aims to improve drug safety and establish bio-similarity in its offerings.

Compass Therapeutics

Series A in 2015
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.

Adored

Seed Round in 2015
Adored, Inc. is a loyalty experience platform that offers a mobile application designed for restaurants, bars, coffee shops, ski resorts, and various attractions. The app utilizes iBeacon indoor location technology to automatically reward customers, enhancing their experiences and encouraging repeat visits. By fostering relationships between businesses and their loyal customers, Adored aims to influence casual visitors and attract new clientele. The application, available on both Apple iOS and Android devices, has been downloaded over 10,000 times and is active in numerous locations. Founded in 2014 and based in Manchester, New Hampshire, Adored focuses on building brand loyalty and increasing the lifetime value of customers through innovative rewards and engaging experiences.

FieldLens

Series A in 2014
FieldLens, Inc. is a provider of an online field management tool designed to enhance communication and collaboration among construction project teams. Founded in 2011 and based in New York, the company offers a mobile platform that allows users to access job-site data in real-time from smartphones, tablets, or the web. This tool helps team members understand their current tasks and provides decision-makers with an overview of projects without needing to be onsite, facilitating the identification of trends and top performers. FieldLens also automates daily reports and tracks field progress, turning simple updates into valuable insights for construction projects. As of December 2020, FieldLens operates as a subsidiary of RedTeam Software, LLC.

HELIX

Series A in 2014
HELIX, originally known as Flux and the first spin-out from Google X, is based in Oakland, California. The company initially focused on generative building design but shifted in 2019 to address the challenges of digitizing buildings. HELIX developed the HELIX Creator platform, which allows architects, engineers, builders, and owner-operators to utilize LiDAR and photogrammetry for capturing precise building geometry, transforming it into practical plans and models. This platform provides users with timely access to accurate 2D and 3D information, as well as essential documents and data related to buildings. HELIX's technology is instrumental in assessing building potential, planning renovations, and detailed documentation for disaster preparedness. The company emphasizes the importance of accurate and easily accessible data to fully realize the capabilities of Digital Twins.

Sketchfab

Seed Round in 2013
Sketchfab, Inc. operates a platform that facilitates the publishing, discovery, and sharing of three-dimensional content. Founded in 2012 and headquartered in New York, with an additional office in Paris, the company has cultivated a large community of creators who collectively contribute millions of 3D models. This platform not only empowers users to showcase their work but also allows for immersive and interactive experiences. Furthermore, Sketchfab offers a marketplace where buyers and sellers can confidently transact 3D models, utilizing features such as a real-time viewer and model inspector to enhance the purchasing experience.

Newforma

Series D in 2013
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.

Avedro

Series D in 2013
Avedro, Inc. is a medical device and pharmaceutical company specializing in the treatment of corneal disorders, particularly corneal ectatic conditions and refractive errors. The company has developed the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems that utilize ultraviolet A (UVA) light, alongside a range of single-use riboflavin drug formulations. These technologies are primarily aimed at treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also focuses on advancing the science of Thermo-biomechanics, exemplified by its Keraflex procedure, a non-invasive method for corneal reshaping that preserves the cornea's biomechanical integrity. The company's products are marketed to ophthalmologists, hospitals, and ambulatory surgery centers in the United States and through international distributors. Avedro, originally established as ThermalVision, Inc. in 2002, is headquartered in Waltham, Massachusetts, and operates as a subsidiary of Glaukos Corporation.

Avitide

Series A in 2013
Avitide, Inc. is a company that specializes in the discovery, manufacturing, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, Avitide focuses on enhancing the purification of therapeutic proteins through its innovative affinity separation technology. This technology helps clients streamline bioprocess development timelines, mitigate program risks, and lower manufacturing costs while ensuring scalability for commercial applications. The company develops customized solutions for a variety of life-saving therapeutics, including enzymes, multi-specific antibodies, gene therapies, and vaccines. By utilizing rapid development techniques for chromatography resins, Avitide aims to improve drug safety and establish bio-similarity in its offerings.

Mosaic Storage Systems

Series A in 2013
Mosaic Storage Systems, founded in 2011 and based in Nashua, New Hampshire, specializes in digital asset storage services aimed at professional and prosumer photographers. The company provides a platform for users to store digital copies of their photographs on secure servers, facilitating easy access and sharing via the internet. This service allows photographers to manage their digital assets effectively, ensuring their work is both safely stored and readily accessible.

Airstone

Venture Round in 2013
Airstone is focused on providing specialized Infrastructure as a Service (IaaS) solutions tailored for Big Data customers. The company has developed a proprietary networking fabric named Ultramarine, which offers significant advantages in price performance compared to existing data center networking fabrics. Ultramarine is distinguished by its low latency and high bandwidth per node, making it a compelling choice for high-performance computing applications.

Vets First Choice

Venture Round in 2012
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.

PCD Partners

Venture Round in 2011
PCD Partners, Inc. specializes in developing and delivering web-based platforms tailored for healthcare organizations, including physician groups, hospitals, and accountable care organizations in the United States. The company focuses on fostering collaboration between hospitals and physicians to enhance clinical outcomes and financial performance. PCD Partners offers a co-management solution that facilitates the integration of healthcare systems and improves overall performance. Additionally, it provides a cloud-based platform that supports healthcare alignment structures and quality improvement initiatives. The company also offers training programs in Lean Six Sigma methodologies, along with project management software designed specifically for healthcare delivery. Based in Lebanon, New Hampshire, PCD Partners comprises a team of experienced physicians, academics, and entrepreneurs dedicated to advancing medical quality and practice improvement.

Wingu

Series A in 2011
Wingu develops software aimed at improving the operational efficiency of pharmaceutical research and discovery. The company is creating a metrics-driven cloud platform that facilitates the management, analysis, and collaboration of scientific data. By simplifying information exchange for researchers and providing comprehensive project insights for managers, Wingu enables executives to make better and quicker decisions through deep analytics.

enVista

Series B in 2010
enVista LLC is a consulting and technology services provider specializing in supply chain management for manufacturers, distributors, and omni-channel retailers. Founded in 2002 and based in Carmel, Indiana, the company offers a wide range of services, including demand planning and management, workforce management, transportation consulting, and facility design. enVista also provides global freight audit and payment solutions, business intelligence dashboards, and freight tracking and optimization. In addition, the company delivers cloud computing solutions, IT consulting, and managed IT services. Its offerings encompass a unified commerce platform, order management systems, point of sale solutions, and e-commerce services, along with Microsoft business solutions and data analytics. With additional offices in locations such as Columbus, Mississippi, Liverpool, UK, Hyderabad, India, and Houston, Texas, enVista aims to help clients reduce operating costs, enhance customer service, and improve profitability through innovative solutions and deep domain expertise.

SpaceClaim

Series D in 2010
SpaceClaim Corporation specializes in the development and marketing of 3D direct modeling software designed to assist engineers, product designers, and manufacturers throughout the product development process. Its primary offerings include SpaceClaim Engineer, which facilitates the creation of 3D designs for prototyping and analysis, and SpaceClaim Style, an industrial design tool for conceptual design validation. Additionally, the company provides SpaceClaim Viewer, allowing users to open and measure designs and drawings. SpaceClaim also offers educational licenses and training programs for academic institutions in North America. The company’s products support various applications, including conceptual engineering and manufacturing engineering, and are distributed through a network of resellers both domestically and internationally. Founded in 2005, SpaceClaim is headquartered in Concord, Massachusetts, with additional offices in France and Japan.

enVista

Debt Financing in 2010
enVista LLC is a consulting and technology services provider specializing in supply chain management for manufacturers, distributors, and omni-channel retailers. Founded in 2002 and based in Carmel, Indiana, the company offers a wide range of services, including demand planning and management, workforce management, transportation consulting, and facility design. enVista also provides global freight audit and payment solutions, business intelligence dashboards, and freight tracking and optimization. In addition, the company delivers cloud computing solutions, IT consulting, and managed IT services. Its offerings encompass a unified commerce platform, order management systems, point of sale solutions, and e-commerce services, along with Microsoft business solutions and data analytics. With additional offices in locations such as Columbus, Mississippi, Liverpool, UK, Hyderabad, India, and Houston, Texas, enVista aims to help clients reduce operating costs, enhance customer service, and improve profitability through innovative solutions and deep domain expertise.

Adimab

Series D in 2010
Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.

Vico Software

Series B in 2009
Vico Software specializes in providing software and services tailored for the building construction industry across Europe, the Middle East, and the Americas. The company's core product, the Vico Office Suite, features a construction-oriented 5D BIM environment that enhances project management and collaboration. Key components include the Vico Office Client, which facilitates the publishing and integration of 3D models from various BIM sources, and the Vico Takeoff Manager, designed to generate precise quantity takeoffs based on 3D models. Additionally, Vico Software offers the Vico Cost Planner for cost calculation and estimating, the Vico Cost Explorer for real-time budget tracking, and the Vico Doc Set Manager for efficient drawing management. The company also provides an online training program and various consulting and implementation services to support clients. Founded in 2007 and headquartered in Boulder, Colorado, Vico Software serves building owners, general contractors, and construction managers, with additional offices in the United States, the United Kingdom, Finland, and Hungary.

enVista

Venture Round in 2009
enVista LLC is a consulting and technology services provider specializing in supply chain management for manufacturers, distributors, and omni-channel retailers. Founded in 2002 and based in Carmel, Indiana, the company offers a wide range of services, including demand planning and management, workforce management, transportation consulting, and facility design. enVista also provides global freight audit and payment solutions, business intelligence dashboards, and freight tracking and optimization. In addition, the company delivers cloud computing solutions, IT consulting, and managed IT services. Its offerings encompass a unified commerce platform, order management systems, point of sale solutions, and e-commerce services, along with Microsoft business solutions and data analytics. With additional offices in locations such as Columbus, Mississippi, Liverpool, UK, Hyderabad, India, and Houston, Texas, enVista aims to help clients reduce operating costs, enhance customer service, and improve profitability through innovative solutions and deep domain expertise.

SpaceClaim

Series C in 2009
SpaceClaim Corporation specializes in the development and marketing of 3D direct modeling software designed to assist engineers, product designers, and manufacturers throughout the product development process. Its primary offerings include SpaceClaim Engineer, which facilitates the creation of 3D designs for prototyping and analysis, and SpaceClaim Style, an industrial design tool for conceptual design validation. Additionally, the company provides SpaceClaim Viewer, allowing users to open and measure designs and drawings. SpaceClaim also offers educational licenses and training programs for academic institutions in North America. The company’s products support various applications, including conceptual engineering and manufacturing engineering, and are distributed through a network of resellers both domestically and internationally. Founded in 2005, SpaceClaim is headquartered in Concord, Massachusetts, with additional offices in France and Japan.

FetchDog

Series A in 2009
FetchDog is an online destination for dog owners to shop, learn and socialize. They offer passionate dog people a place to find quality dog supplies and credible advice on their dog’s health and wellness. Their products include pets, dog beds, dog homes, dog collars, leashes and harnesses, dog apparel, dog toys, treats, bowls, dog travel, and more.

Adimab

Series C in 2008
Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.

Newforma

Series C in 2008
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.

enVista

Venture Round in 2008
enVista LLC is a consulting and technology services provider specializing in supply chain management for manufacturers, distributors, and omni-channel retailers. Founded in 2002 and based in Carmel, Indiana, the company offers a wide range of services, including demand planning and management, workforce management, transportation consulting, and facility design. enVista also provides global freight audit and payment solutions, business intelligence dashboards, and freight tracking and optimization. In addition, the company delivers cloud computing solutions, IT consulting, and managed IT services. Its offerings encompass a unified commerce platform, order management systems, point of sale solutions, and e-commerce services, along with Microsoft business solutions and data analytics. With additional offices in locations such as Columbus, Mississippi, Liverpool, UK, Hyderabad, India, and Houston, Texas, enVista aims to help clients reduce operating costs, enhance customer service, and improve profitability through innovative solutions and deep domain expertise.

Makeover Solutions

Series A in 2007
Makeover Solutions, Inc., a marketing company, provides Web-based virtual makeovers. The company builds online communities for women users interested in beauty and beauty care conversations. Its Personal Makeover helps companies to create an online relationship with their customers. The company was incorporated in 2007 and is based in New York, New York.

SpaceClaim

Series B in 2007
SpaceClaim Corporation specializes in the development and marketing of 3D direct modeling software designed to assist engineers, product designers, and manufacturers throughout the product development process. Its primary offerings include SpaceClaim Engineer, which facilitates the creation of 3D designs for prototyping and analysis, and SpaceClaim Style, an industrial design tool for conceptual design validation. Additionally, the company provides SpaceClaim Viewer, allowing users to open and measure designs and drawings. SpaceClaim also offers educational licenses and training programs for academic institutions in North America. The company’s products support various applications, including conceptual engineering and manufacturing engineering, and are distributed through a network of resellers both domestically and internationally. Founded in 2005, SpaceClaim is headquartered in Concord, Massachusetts, with additional offices in France and Japan.

enVista

Series A in 2007
enVista LLC is a consulting and technology services provider specializing in supply chain management for manufacturers, distributors, and omni-channel retailers. Founded in 2002 and based in Carmel, Indiana, the company offers a wide range of services, including demand planning and management, workforce management, transportation consulting, and facility design. enVista also provides global freight audit and payment solutions, business intelligence dashboards, and freight tracking and optimization. In addition, the company delivers cloud computing solutions, IT consulting, and managed IT services. Its offerings encompass a unified commerce platform, order management systems, point of sale solutions, and e-commerce services, along with Microsoft business solutions and data analytics. With additional offices in locations such as Columbus, Mississippi, Liverpool, UK, Hyderabad, India, and Houston, Texas, enVista aims to help clients reduce operating costs, enhance customer service, and improve profitability through innovative solutions and deep domain expertise.

Newforma

Series C in 2007
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.

Flurry

Series A in 2007
Flurry, Inc. is a mobile application analytics and advertising platform that helps businesses build, measure, advertise, and monetize their mobile applications. Founded in 2005 and headquartered in San Francisco, Flurry offers a suite of products, including Flurry Analytics, which enables businesses to analyze consumer interactions across over 400,000 applications. The platform tracks more than 1 billion end-user sessions monthly and provides insights into audience reach, engagement, retention, and revenue. Flurry also offers solutions such as AppSpot, which serves targeted ads to enhance click-through rates and revenue, and Flurry Personas, which identifies consumer segments with shared interests. Additionally, Flurry Marketplace connects publishers with advertisers through a single SDK integration. With a user-friendly setup that takes just five minutes, Flurry's services are utilized by over 125,000 companies and are compatible with various mobile platforms, including iOS, Android, and Windows Phone.

Handmark

Series B in 2006
Handmark is a software development company specializing in applications for various mobile platforms including Android, Blackberry, Palm, and Windows. Their product portfolio spans across multiple categories such as games, personalization solutions, ringtones, utilities, tools, sports, business productivity, fitness health, news information, reference, and entertainment. Notably, they have developed the Tantao News Mobile Reader for BlackBerry smartphones, offering global and domestic news sourced from Chinese media outlets.

SpaceClaim

Series A in 2005
SpaceClaim Corporation specializes in the development and marketing of 3D direct modeling software designed to assist engineers, product designers, and manufacturers throughout the product development process. Its primary offerings include SpaceClaim Engineer, which facilitates the creation of 3D designs for prototyping and analysis, and SpaceClaim Style, an industrial design tool for conceptual design validation. Additionally, the company provides SpaceClaim Viewer, allowing users to open and measure designs and drawings. SpaceClaim also offers educational licenses and training programs for academic institutions in North America. The company’s products support various applications, including conceptual engineering and manufacturing engineering, and are distributed through a network of resellers both domestically and internationally. Founded in 2005, SpaceClaim is headquartered in Concord, Massachusetts, with additional offices in France and Japan.

GlycoFi

Series C in 2005
GlycoFi is a biotech firm based in Lebanon, New Hampshire, focused on developing biotherapeutics through its innovative glycan optimization technology. The company has engineered a library of yeast strains that enable precise human glycosylation, resulting in therapeutic proteins suitable for drug development. GlycoFi aims to establish its own pipeline of therapeutic products while also collaborating with other pharmaceutical companies to enhance their drug offerings. Founded in 2000, GlycoFi operates as a subsidiary of Merck & Co., Inc., further expanding its capabilities in the biotherapeutics landscape.

Newforma

Series B in 2005
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.

Handmark

Series A in 2005
Handmark is a software development company specializing in applications for various mobile platforms including Android, Blackberry, Palm, and Windows. Their product portfolio spans across multiple categories such as games, personalization solutions, ringtones, utilities, tools, sports, business productivity, fitness health, news information, reference, and entertainment. Notably, they have developed the Tantao News Mobile Reader for BlackBerry smartphones, offering global and domestic news sourced from Chinese media outlets.

Medical Metrx Solutions

Series B in 2003
Medical Metrx Solutions, Inc. (formerly Medical Media Systems) is a medical technology and services company providing diagnostic quality 3-D virtual models of patient anatomy built from CT and MR scan data using the company’s proprietary modeling software. The company’s models — which contain more precise quantitative measurement information than competitors’ offerings — are provided to interventional radiologists and vascular surgeons who use them for pre-operative planning and post-operative surveillance of their patients’ conditions. The company was acquired by AIG Altaris Health Partners in 2005.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.